Loading...
Explore key FAQs on international drug sourcing for employers. Learn how this strategy can reduce pharmacy spend by accessing safe, lower-cost medications from abroad.
With U.S. brand-name drug prices now 3-4x higher than other countries, employers are eyeing international sourcing to save up to 10% on pharmacy costs. Here’s what you need to know:
International drug sourcing is the practice of purchasing medications from licensed pharmacies outside the U.S. through a contracted PBM or vendor. These medications are typically:
Shipped directly to members.
Identical or clinically equivalent to U.S. versions.
Sourced from areas with strong regulatory standards like Canada, the UK, or the EU.
The goal of international drug sourcing is to offer members lower prices for the same medications without disrupting care.
U.S. prices for brand-name drugs are over 3x higher than prices in comparable countries, even after rebate adjustments. Drug pricing in the U.S. is higher than in most developed countries due to four key factors:
No centralized price negotiation: In most developed countries, national health systems negotiate directly with drug manufacturers to set prices. In contrast, private insurers, PBMs, and employers negotiate prices in the U.S., which means less leverage and higher prices.
Higher innovation costs: U.S. drug prices often reflect not just the cost to manufacture a medication, but the cost to bring it to market. This includes years of research, clinical trials, and regulatory approvals, plus the sunk costs of failed drug candidates.
Strict regulatory standards: U.S. distribution requirements mandate serial numbers, barcoding, and tracking of all prescription drugs from manufacturer to pharmacy. These protections reduce the risk of counterfeit drugs but also raise packaging, logistics, and compliance costs compared to markets with less stringent requirements.
Not all medications are a good fit for international sourcing. The strategy tends to focus on:
High-cost brand-name drugs where price differentials are most dramatic.
Select generics that are cheaper abroad despite being off-patent.
Drugs with low or no rebates where savings from sourcing outweigh rebate value.
Specialty or maintenance medications that members take regularly and can receive via mail-order.
Each case requires a cost-benefit analysis to determine sourcing suitability.
Employers can save up to 10% on total pharmacy spend through international sourcing, depending on the mix of drugs and member participation. The greatest savings are often found in drug classes where rebate structures offer minimal offsets to high list prices.
That said, results vary. Sourcing works best as part of a broader pharmacy strategy, not a standalone solution.
International sourcing falls into a complex regulatory space. Many international sourcing models are built around U.S.-based vendors who coordinate fulfillment from pharmacies licensed and regulated in their home countries. Employers must work with reputable vendors who can demonstrate compliance with applicable regulations and transparency in their sourcing and shipping practices. It’s important to ensure:
Vendors are licensed and operate under clear regulatory authority.
Products are sourced from legitimate pharmacies in countries with comparable safety standards.
Fulfillment and tracking comply with customs laws and any relevant FDA guidance.
At this time, tariff discussions mostly target bulk imports and China-made generics, not the mail-order programs that would be used in employer-sponsored international sourcing.
These programs typically rely on FDA enforcement discretion, which permits individuals to import up to a 90-day supply of non-controlled medications for personal use. Trusted vendors remain compliant with all licensing, safety, and shipping regulations, keeping these programs protected from current trade policy risks.
When considering international sourcing, organizations should carefully weigh:
Net cost savings: Will savings from lower drug prices outweigh the loss of manufacturer rebates?
Member impact: How much effort will enrollment, transfers, and fulfillment require from members?
Operational fit: Does the program integrate smoothly with current benefits and pharmacy vendors?
International sourcing is not a fit for every drug or every member population, but it can be a strong addition to a cost-containment strategy when used correctly.
Yes, but the impact can be managed. Members must engage more directly in the process than with standard retail or mail-order pharmacy use. Typical steps or changes include:
Enrolling in the international sourcing program and providing insurance information, shipping address, and payment details.
Having prescriptions transferred to an international partner pharmacy.
Receiving 90-day supplies by mail.
There may be some initial friction and longer lead time on first fills, but some vendors and pharmacy benefit managers (PBMs) provide support teams to help members navigate the transition. Over time, members benefit from predictable 90-day supplies and often lower out-of-pocket costs.
International sourcing is just one piece of the puzzle. To see what else is shaping the future of pharmacy benefits cost management, read up on the 4 key trends in PBM.
Our PBM Annual Report is here!
See how we’re ushering in the next era of pharmacy innovation.
Pharmacists play a key role in improving healthcare and reducing costs. Discover how clinical pharmacists enhance team well-being and drive better outcomes.
Read moreRead our 2024 PBM Annual Report and see how Rightway is meeting growing market demand without compromising what matters most: transformational cost savings, industry-leading client service, and white-glove member support.
Read moreLearn the truth about traditional PBMs. Discover the six biggest lies they tell employers—and how Rightway offers a transparent, client-first alternative.
Read more